Clinical Trials Directory

Trials / Unknown

UnknownNCT03778125

Multidrug Resistant Shigella Infection in Bangladesh

Clinical and Microbiologic Outcomes in Patients Treated for Multidrug-resistant Shigella Infections in Dhaka, Bangladesh

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
University of Virginia · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this project is to systematically collect clinical and nutritional outcomes information on patients treated for Shigella infection so that physicians and clinical laboratories can better define which Shigella infections are "resistant" to antibiotics and which are "susceptible", focusing on azithromycin a last-line drug to treat drug resistant Shigella

Detailed description

2000 suspected Shigella cases will be recruited from International Centre for Diarrhoeal Disease Research hospital, Dhaka who are presenting with diarrhea at the hospital. A stool sample will be collected from the participants after consenting by the study staff. Stool microscopy will be performed to see the white blood cells(WBC) and red blood cells (RBC). If WBC \> 10 HPF (4) with any RBC present, culture will be performed from this stool to identify Shigella. Such patients with invasive diarrhea are treated with azithromycin per local standard of care. Enrolled participant will be invited for further follow up when culture from the stool is Shigella positive. Minimal inhibitory concentration (MIC) testing of Shigella isolates and Molecular testing of Shigella isolates will be performed from Shigella cultures. This is an observational study. This study does not provide any treatment to the study participants; they will receive treatment as per International Centre for Diarrhoeal Disease Research Dhaka hospital guidelines. We will then examine the effect of the azithromycin minimal inhibitory concentration on clinical outcome.

Conditions

Timeline

Start date
2018-12-13
Primary completion
2019-12-31
Completion
2020-01-31
First posted
2018-12-19
Last updated
2019-01-29

Locations

1 site across 1 country: Bangladesh

Source: ClinicalTrials.gov record NCT03778125. Inclusion in this directory is not an endorsement.